Cargando…
Anticholinergic Burden and Cognitive Performance in Patients With Schizophrenia: A Systematic Literature Review
Objective: Cognitive impairment in schizophrenia forms the key cause of the disease's disability, leading to serious functional, and socioeconomic implications. Dopaminergic-cholinergic balance is considered essential to cognitive performance in schizophrenia and patients are often treated with...
Autores principales: | Georgiou, Rafaella, Lamnisos, Demetris, Giannakou, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748260/ https://www.ncbi.nlm.nih.gov/pubmed/35027893 http://dx.doi.org/10.3389/fpsyt.2021.779607 |
Ejemplares similares
-
The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia
por: Ang, Mei San, et al.
Publicado: (2017) -
Small-Area Geographic and Socioeconomic Inequalities in Colorectal Cancer in Cyprus
por: Giannakou, Konstantinos, et al.
Publicado: (2022) -
A case report—“When less is more”: controlled inpatient reduction of anticholinergic burden in a patient with clozapine-resistant schizophrenia
por: Pjevac, Milica, et al.
Publicado: (2023) -
Dual Trigger with Gonadotropin Releasing Hormone Agonist and Human Chorionic Gonadotropin of Fresh Autologous Cycles in High Responders: A Systematic Review
por: Vyrides, Andreas A, et al.
Publicado: (2022) -
Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
por: Hori, Hikaru, et al.
Publicado: (2022)